Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...
19hon MSNOpinion
You are some rich guy's exit strategy: Vivian Tu says your guy friends are getting duped by Elon Musk's SpaceX IPO. Protect yourself now
The former JPMorgan trader says the much-hyped IPO is really a cash-out for early investors who got in a decade ago, warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results